Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
Abstract
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosutinib...
Paper Details
Title
Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
Published Date
May 1, 2021
Journal
Volume
9
Issue
5
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History